To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.


Already Have an Account?

Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Vol:254 Issue:1 Number:1 ISSN#:2564-2537
ACE Report #14534
Ace Report Cover Osteoarthritis

Leukocyte-Rich vs. Leukocyte-Poor Platelet-Rich Plasma for Knee Osteoarthritis

How to Cite

OrthoEvidence. Leukocyte-Rich vs. Leukocyte-Poor Platelet-Rich Plasma for Knee Osteoarthritis. ACE Report. 2021;254(1):1. Available from:

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Leukocyte-Rich versus Leukocyte-Poor Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis: A Double-Blind Randomized Trial

Am J Sports Med. 2022 Mar;50(3): 609-617.

Contributing Authors:
A Di Martino A Boffa L Andriolo I Romandini SA Altamura A Cenacchi V Roverini S Zaffagnini G Filardo

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


192 patients with unilateral, symptomatic knee osteoarthritis were randomized to receive 3 weekly intra-articular injections of leukocyte-rich platelet-rich plasma (n=96) or leukocyte-poor platelet-rich plasma (n=96). The primary outcome of interest was the International Knee Documentation Committee (IKDC) score at 12 months. Secondary outcomes of interest included the Knee Injury and Osteoarthrit...

Ace Report Preview Image
CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

For Reprints and Permissions, click here

Please Login or Join to leave comments.